These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 12491810)

  • 1. [Pharmacological profile and clinical effects of montelukast sodium (Singulair chewable tablet), an antiasthmatic agent].
    Suzuki J; Nishikibe M
    Nihon Yakurigaku Zasshi; 2002 Nov; 120(5):343-52. PubMed ID: 12491810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacology of montelukast sodium (Singulair), a potent and selective leukotriene D4 receptor antagonist.
    Jones TR; Labelle M; Belley M; Champion E; Charette L; Evans J; Ford-Hutchinson AW; Gauthier JY; Lord A; Masson P
    Can J Physiol Pharmacol; 1995 Feb; 73(2):191-201. PubMed ID: 7621356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years.
    Knorr B; Franchi LM; Bisgaard H; Vermeulen JH; LeSouef P; Santanello N; Michele TM; Reiss TF; Nguyen HH; Bratton DL
    Pediatrics; 2001 Sep; 108(3):E48. PubMed ID: 11533366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Montelukast.
    Markham A; Faulds D
    Drugs; 1998 Aug; 56(2):251-6; discussion 257. PubMed ID: 9711449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A series of non-quinoline cysLT1 receptor antagonists: SAR study on pyridyl analogs of Singulair.
    Guay D; Gauthier JY; Dufresne C; Jones TR; McAuliffe M; McFarlane C; Metters KM; Prasit P; Rochette C; Roy P; Sawyer N; Zamboni R
    Bioorg Med Chem Lett; 1998 Mar; 8(5):453-8. PubMed ID: 9871597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhaled montelukast inhibits cysteinyl-leukotriene-induced bronchoconstriction in ovalbumin-sensitized guinea-pigs: the potential as a new asthma medication.
    Muraki M; Imbe S; Sato R; Ikeda Y; Yamagata S; Iwanaga T; Tohda Y
    Int Immunopharmacol; 2009 Oct; 9(11):1337-41. PubMed ID: 19706339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Montelukast. No current use for asthma.
    Can Fam Physician; 2000 Jan; 46():86-99. PubMed ID: 10660791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on the use of montelukast in pediatric asthma.
    Capristo C; Rigotti E; Boner AL
    Allergy Asthma Proc; 2006; 27(4):312-8. PubMed ID: 16948343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Montelukast, a leukotriene-receptor antagonist, for the treatment of mild asthma and exercise-induced bronchoconstriction.
    Leff JA; Busse WW; Pearlman D; Bronsky EA; Kemp J; Hendeles L; Dockhorn R; Kundu S; Zhang J; Seidenberg BC; Reiss TF
    N Engl J Med; 1998 Jul; 339(3):147-52. PubMed ID: 9664090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of exercise training and montelukast in children with mild asthma.
    Bonsignore MR; La Grutta S; Cibella F; Scichilone N; Cuttitta G; Interrante A; Marchese M; Veca M; Virzi' M; Bonanno A; Profita M; Morici G
    Med Sci Sports Exerc; 2008 Mar; 40(3):405-12. PubMed ID: 18379200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Montelukast: a review of its therapeutic potential in persistent asthma.
    Jarvis B; Markham A
    Drugs; 2000 Apr; 59(4):891-928. PubMed ID: 10804041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenosine A1 receptor antagonist versus montelukast on airway reactivity and inflammation.
    Nadeem A; Obiefuna PC; Wilson CN; Mustafa SJ
    Eur J Pharmacol; 2006 Dec; 551(1-3):116-24. PubMed ID: 17027749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Montelukast inhibits inflammatory responses in small airways of the Guinea-pig.
    Harrison S; Gatti R; Baraldo S; Oliani KL; Andre E; Trevisani M; Gazzieri D; Saetta M; Geppetti P
    Pulm Pharmacol Ther; 2008; 21(2):317-23. PubMed ID: 17905619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacology of leukotriene receptor antagonists.
    Aharony D
    Am J Respir Crit Care Med; 1998 Jun; 157(6 Pt 2):S214-8; discussion S218-9, S247-8. PubMed ID: 9647602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of montelukast (MK-0476), a cysteinyl leukotriene receptor antagonist, on allergen-induced airway responses and sputum cell counts in asthma.
    Diamant Z; Grootendorst DC; Veselic-Charvat M; Timmers MC; De Smet M; Leff JA; Seidenberg BC; Zwinderman AH; Peszek I; Sterk PJ
    Clin Exp Allergy; 1999 Jan; 29(1):42-51. PubMed ID: 10051701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Montelukast prevents the decrease of interleukin-10 and inhibits NF-kappaB activation in inflammatory airway of asthmatic guinea pigs.
    Wu Y; Zhou C; Tao J; Li S
    Can J Physiol Pharmacol; 2006 May; 84(5):531-7. PubMed ID: 16902598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Montelukast in childhood asthma: what is the evidence for its use?
    Amlani S; McIvor RA
    Expert Rev Respir Med; 2011 Feb; 5(1):17-25. PubMed ID: 21348582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Montelukast sodium for exercise-induced asthma.
    de Benedictis FM; Vaccher S; de Benedictis D
    Drugs Today (Barc); 2008 Nov; 44(11):845-55. PubMed ID: 19180262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Montelukast: data from clinical trials in the management of asthma.
    Blake KV
    Ann Pharmacother; 1999 Dec; 33(12):1299-314. PubMed ID: 10630831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Montelukast treatment attenuates the increase in myofibroblasts following low-dose allergen challenge.
    Kelly MM; Chakir J; Vethanayagam D; Boulet LP; Laviolette M; Gauldie J; O'Byrne PM
    Chest; 2006 Sep; 130(3):741-53. PubMed ID: 16963671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.